Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Nice steady tick up over last 5 trading day. Up 17% plus today on low volume. In the current markets I would have expected some pull back, by now on no news.
I am expecting a pre close trading statement soon as they released one last year. It was on the 23rd Jan. Can't see any reason not to release one this year, similar time.
Also, as the assessment on the CardioQ system by the NHS CENTRE FOR EVIDENCE-BASED PURCHASING (CEP) is due an update on 13th of this month timing could be perfect for a sp surge, obviously counting on a positive update that is but with 2 delays already, don't hold your breath. It does make you wonder why the NHS have to sit on this for so long, when all the evidence to prove evidence based purchase (positive) is literally starring them in the face. Just how much more evidence do these muppets need.

Yes has improved nicely and despite saying I had enough I did a small top up on 31/12 that really is it now. I think this has the potential to go quite well in terms of the sp, like you say the evidence is there, it just needs to be recognised by the purse holders, and slowly but surely this is happening.
2517

As I understand it although the powers that be (NHS Trusts) don't have to follow recommendations made by THE NHS CENTRE FOR EVIDENCE-BASED PURCHASING (CEP) they would find it very difficult to not follow the said recommendations, if it is shown that the product shows best value for money.
An interesting explanation re what they (CEP) do.
http://www.pasa.nhs.uk/PASAWeb/NHSprocurement/CEP

Don't hold your breath.

The NHS (CEP) projects are listed in order of intended publication date, soonest first. There are 14 that have an intended publication date prior to the Deltex connected one. The project top of the list still has an intended publication date of early 2008. Yes that's not a typo error, 2008 is correct. So no doubt we will see many updates, where the only difference is yet another update due date. No wonder nothing ever gets done.
Pathetic or what.
Lets just hope that the list is juggled about a bit, if/when obstacles are overcome.
When the project is finally published, I will receive a full project report, so will post here.
If I live that long.

NHS (CEP) update or not.
The only update is yet again another report estimated date, now being 20/01/09.

Due to the almost static none action by the above (still 14 projects with priority dates earlier than the CadioQ assessment) I have sent the following E-Mail to the NIHR.

I am conducting research on the workings of the NIHR Health Technology Assessment programme.

You state that, 'Projects are listed in order of intended publication date, soonest first. Followed by completed projects that do not require publication'.

Often these so called publication dates have passed. Please see example below which is the first project on your current list, which is still showing Estimated Publication date of Early 2008. As it is now 2009 how can this estimated date still be relevant. This gives the impression that proposed dates are just churned over, with no real information of progress. If estimated publication dates are up to 12 months out, what's the point of publishing said estimated dates.

Example..This is the first on the list.
Docetaxel for the adjuvant treatment of early breast cancer. HTA Ref: 05/53/01.
Research Type: NICE Evidence Review Group Report (ERG).
(ERG report received)
Estimated publication date in Supplement to the HTA journal series: Early 2008.
END.

I will no longer post info re this unless there IS an update of any relevance.
I will of course post any reply from my e-mail (don't hold your breath as I am not expecting one).
The CardioQ project was first looked at by the above in March 2007. This just goes to show the huge huddles that Deltex have to overcome.
Slow, slow stop should be the motto of the NIHR.

Sadly this is an all too common occurrence these days, in as much as people in prominent positions gladly keep taking the money and do diddley squat for it, some MP's, bankers, the social services and the NHS, to name just a few. I look forward to reading any reply you may get greekman, course the danger is if they do respond to your e-mail it will put the update back another 12 months.
I hasten to add there are a good many very hard working people in the occupations above, it just seems to be the decision makers who are not up to the task.
2517

Fully agree. Plenty of hard working indians, with even more none productive chiefs.
But as long as failure or/and none productivity is rewarded, nothing will change.

NIHR HTA programme up date.
It appears that although the next stated update from the last (13/01/09) was to be today, but for some reason an update was published on 16/01/09.
The good news is the project at the top of the list now has a estimated publish date of Jan 2009, whereas a few weeks ago such dates were Jan 2008, so somewhat out of date (I would like to think my e-mail giving a diplomatic kick up the ass did it, but I doubt it very much).
The point is since the 13th, seven projects have been published leaving Deltex Cardio now 8th on the projected publishing timescale (from 14th a week ago).
Might not mean much but at least their (Deltex) project is moving nearer the top in priority.
Will post further update after market close tonight.
Hope I'm not going to deep re this (boring) but I feel the result of this project research paper will be a main catalyst in the take up of the Cardio system in the UK.

Note. I am now signed up with the NIHR HTA programme so will be informed of any updates as and when they occur. I will also receive notification as/when the Deltex project is published, so will post immediately, although there will probably be a RNS at the same time.

greekman---------not at all boring, always look forward to your posts, and with DEMG moving up the ladder it looks promising, from what I recall the vast majority of DEMG rns's have been positive anyway, and I don't think that will change now, this is a must have for hospitals worldwide, and for the NHS it should attain Standard of Care status at some point.
2517

Thanks George,

The close of market update from CAP is only a change of date re next update is 20/01/09.
For some reason the Deltex Project has slipped down the priority publication list from 8th this morning to the 16th. So it appears that there are now another 8 projects that have an earlier projected publication date. Not reading too much into this as many projects may be far simpler in discipline and technology to deal with.
Also a couple of projects awaiting publication have now been published ahead of others that were above them in the list. So it appears events such as this are common place. Due to this I will look at the list in a different light of importance.
Also if the only updates in the future are limited to a change of date, I will not post such info unless it is relevant.

Greek.

From the Pre close update.

Several snippets of hope for future sales.
The bits I like are....made significant progress in all of its key markets
for the third consecutive year.......group probe sales in each quarter were ahead of the corresponding quarter in the preceding year.......International sales and marketing operations contributed to a sustainable reduction in the level of underlying cash burn.......reduce or defer wherever possible the majority of such discretionary expenditure until the Company's expected continuing growth.

The future is looking better than ever.

There is so much to like about the progress being made, the spanish operation(sorry about that) look excellent (close to being a standard of care) as does the USA, and with Germany just starting out the sale of probes is still in it's infancy really, and as more hospitals take up the Cardio-Q so the sale of probes should increase substantially. Deferring spending on discretionary items makes sense in the current climate, however I believe this may be to DEMG's advantage, as healthcare spending restrictions are implemented so the adoption of the Cardio-Q becomes more compelling, as it's proven to be more cost effective to use.
2517

Down 6.25% this am (75p). Tempted to invest more but already have Deltex as a very large percentage of my share portfolio, so will probably resist. Although looking cheep at this price, remember there is no such animal in the stock market world as a sure thing.

The report is out an it is not good. Also the conclusion is unbelievable and appears the findings contradict the conclusion.

Headline.

Study found that, although esophageal Doppler monitoring is likely to be of both clinical and economic benefit in high-risk surgical patients, insufficient evidence is available to recommend its widespread use in critically ill patients.

For further in go to...

Sorry will not allow me to edit post MoneyAm faulty yet again.
Link is http://www.hta.ac.uk/execsumm/summ1307.shtml

This extract says it all.

Data sources
Searches of electronic databases [including MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane Library] and relevant websites until May 2007 were undertaken to identify published and unpublished reports, including previous systematic reviews.

So no evidence was examined since May 2007. Marvellous isn't it.
Because these reports sit gathering in-tray dust, any published title is often as this one is almost 2 years out of date
Lets just hope Deltex put forward a follow up project request, as from those reports post May 2007 appear to have answered many of this projects questions.
Of course this would mean another wait of many months.

Apologies to all.

I have now read the full report in detailed study whereas before I read it with less depth analysis due to the disappointing headline, ( I admit to frustration getting the better of me).

The report as I read it is actually more positive than negative.

What do others think?

Be interesting to see how the market(institutional investors) see it.

It took some reading but I believe the outcome is favourable for DEMG, some areas were unaminously positive for the usage of the ODM, whilst others (thinking mortality rates here) were inconclusive due to the limited number of patients being studied/monitored. Cost effectiveness also appeared inconclusive due to a complete lack of in depth study by those doing the research, it seems they need to price up the extra labour costs involved without the ODM, against the cost effectiveness with the ODM, ie how much money is saved due to less complications and shorter hospital stays.

Summing up I think some of the benefits of using the ODM were pinpointed, but to me those carrying out this study have only done half a job because they have not compared the costs involved sufficiently. aimo of course.
2517

Hi George,

Yes it did take some reading. I have now read it three times, the last time putting certain points to my wife, a retired Nurse with intensive care experience.
Between us we sorted it all out (well almost anyway). We came to the same conclusion as yourself.
Cost effectiveness looks as being the main section that has been covered only since May 2007, with no post project date or trial figures information considered, due to the commencement date of the project start.

Off subject but an example of procrastination in anything official.
In Yorkshire we were one of the areas that suffered in the floods of June 2007, the house opposite was flooded out for over 6 months and others were still out after 18 months. Luckily our house in on a slope so we were OK.
My point is the flood survey took several months to set up, and many more months to be finalised and has only now been put to the final decision committee (council), some 18 months from the flood date. One statement has been released. The areas flooded will be prone to further flood risk if nothing is done.

Sorry again re going off thread but just an example of highly paid so called experts twiddling their thumbs whilst people are flooded out (or even more importantly dying) from lack of decisions such as the use of CardioQ.

RNS out re report.

Deltex are putting a posative slant on the report.
The following extract of the RNS shows why.

'The NIHR report will be a very powerful tool in the hands of the many UK doctors already wanting to incorporate use of the CardioQ-ODM into their practice. Combined with new consensus guidelines on fluid management for surgical patients, the Centre for Evidence-based Purchasing report published last year and the recommendations of the NHS National Technology Adoption Centre's work with CardioQ-ODM due later this year, we are building a substantial body of independent NHS recommendations for the wide-scale adoption of the CardioQ-ODM.
'Much of the further research recommended by NIHR is already in hand. We expect that such additional research will make it increasingly difficult for any hospital to not implement ODM as a standard of care for major surgery.'